Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study
Abstract Beta-blockers have been associated with decreased cancer mortality. However, evidence for lung cancer is sparse and reported beneficial effects might be based on biased analyses. In this so far largest study we investigated the association between β-blocker use and lung cancer survival. The...
Guardado en:
Autores principales: | Janick Weberpals, Lina Jansen, Walter E. Haefeli, Michael Hoffmeister, Martin Wolkewitz, Myrthe P. P. van Herk-Sukel, Pauline A. J. Vissers, Hermann Brenner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a414ffc35a6946debb64e751c040ea6c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Survival of patients with oral cavity cancer in Germany.
por: Stefan Listl, et al.
Publicado: (2013) -
Survival of adults with acute lymphoblastic leukemia in Germany and the United States.
por: Dianne Pulte, et al.
Publicado: (2014) -
Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
por: Hayder M. Al-kuraishy, et al.
Publicado: (2021) -
Heart Failure and MEF2 Transcriptome Dynamics in Response to β-Blockers
por: S. W. Tobin, et al.
Publicado: (2017) -
Transdermal Patches for Delivery of Beta-Blockers
por: Rohaľová S., et al.
Publicado: (2021)